v3 Template
P

Psyence Biomedical Ltd.

Biotechnology / Mental Health New York, USA ~220 employees
Founded
--
Employees (Est.)
~220
11 leaders known
Total Funding
$54.0M
Funding Rounds
4
Last Funding
2024-12-27

About Psyence Biomedical Ltd.

Psyence Biomedical is a life science biotechnology company listed on NASDAQ (PBM), focused on developing botanical, nature-derived psilocybin-based psychedelic medicines. The company combines 'psychedelics' and 'science' to create evidence-based, safe, and effective therapeutics for mental health disorders, with an initial focus on palliative care, targeting anxiety, depression, and related conditions.

Products & Services

Nature-Derived Psilocybin-Based Medicines:Innovative psychedelic therapeutics aimed at treating mental health disorders, particularly in palliative care contexts such as anxiety and depression.

Specialties

Nature-Derived Psychedelic Therapeutics Psilocybin-Based Medicines Mental Health in Palliative Care Clinical Development of Psychedelics

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Private Placement
T: -
FT: Private Placement
A: 2000000
MR: -
FA: $2.0 Million
FAN: 2000000
D: 2024-12-27
FD: 2024-12-27
-
2 RT: Private Placement
T: -
FT: Private Placement
A: 2000000
MR: -
FA: 2.0 million
FAN: 2000000
D: 2024-12-23
FD: 2024-12-23
-
3 RT: Equity Line of Credit
T: -
FT: Equity Line of Credit
A: 25000000
MR: -
FA: $25 million
FAN: 25000000
D: 2024-08-30
FD: 2024-08-30
1 investors
4 RT: Equity Line of Credit (ELOC)
T: -
FT: Equity Line of Credit (ELOC)
A: 25000000
MR: -
FA: $25 million
FAN: 25000000
D: 2024-07-31
FD: 2024-07-31
1 investors
Private Placement Latest
2024-12-27
$2.0M
Private Placement 2024-12-23
$2.0M
Equity Line of Credit 2024-08-30
$25.0M

View 3 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

N

Neil Maresky

Chief Executive Officer

J

Jody Aufrichtig

Co-Founder, Executive Chairman and Director

C

Christopher Bull

Independant Director

S

Seth Feuerstein

Board Member

M

Marc Balkin

Board Member

A

Albert Garcia-Romeu

Chair, Scientific Advisory Board

View 8 more team members with Pro

Unlock Full Team Directory

Recent News

Psyence Biomedical Ltd. Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Biotechnology / Mental Health
Company Size
~220 employees (est.)
Locations
New York, USA

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro